lncRNA ZFAS1 Positively Facilitates Endothelial Ferroptosis via miR-7-5p/ACSL4 Axis in Diabetic Retinopathy DOI Creative Commons
Yu Liu, Zhengyu Zhang, Jing Yang

et al.

Oxidative Medicine and Cellular Longevity, Journal Year: 2022, Volume and Issue: 2022, P. 1 - 17

Published: Aug. 31, 2022

Accumulating evidence has suggested the significant role of long noncoding RNAs (lncRNA) in regulating ferroptosis, while its regulatory mechanism diabetic retinopathy (DR) remains unelucidated. In this work, we first demonstrated that lncRNA zinc finger antisense 1 (ZFAS1) is upregulated high glucose-cultured human retinal endothelial cells (hRECs) and ZFAS1 inhibition attenuated glucose- (HG-) induced which was evidenced by cell viability, total iron ferrous levels, reactive oxygen species (ROS) level, Glutathione Peroxidase 4 (GPX4) expression detection. Mechanistically, validated may act as a competing endogenous RNA competitively binding with microRNA-7-5p (miR-7-5p) modulating downstream molecule acyl-CoA synthetase long-chain family member (ACSL4), now identified classic driver gene ferroptosis process. conclusion, our results demonstrate HG-induced elevation activates hRECs ZFAS1/miR-7-5p/ACSL4 axis serve therapeutic target for dysfunction DR.

Language: Английский

Signaling pathways in Parkinson’s disease: molecular mechanisms and therapeutic interventions DOI Creative Commons

Dong-Chen Xu,

Yong Chen, Yang Xu

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Feb. 21, 2023

Abstract Parkinson’s disease (PD) is the second most common neurodegenerative worldwide, and its treatment remains a big challenge. The pathogenesis of PD may be related to environmental genetic factors, exposure toxins gene mutations beginning brain lesions. identified mechanisms include α-synuclein aggregation, oxidative stress, ferroptosis, mitochondrial dysfunction, neuroinflammation, gut dysbiosis. interactions among these molecular complicate pose great challenges drug development. At same time, diagnosis detection are also one obstacles due long latency complex mechanism. Most conventional therapeutic interventions for possess limited effects have serious side effects, heightening need develop novel treatments this disease. In review, we systematically summarized pathogenesis, especially PD, classical research models, clinical diagnostic criteria, reported therapy strategies, as well newly candidates in trials. We shed light on components derived from medicinal plants that their treatment, with expectation provide summary outlook developing next generation drugs preparations therapy.

Language: Английский

Citations

202

Quercetin Protects against MPP+/MPTP-Induced Dopaminergic Neuron Death in Parkinson’s Disease by Inhibiting Ferroptosis DOI Creative Commons
Zhihao Lin, Yi Liu,

Nai‐Jia Xue

et al.

Oxidative Medicine and Cellular Longevity, Journal Year: 2022, Volume and Issue: 2022, P. 1 - 17

Published: Sept. 5, 2022

Ferroptosis, a novel form of regulated cell death, is caused by accumulation lipid peroxides and excessive iron deposition. This process has been linked to the death dopaminergic neurons in substantia nigra compacta (SNc) Parkinson's disease (PD) patients. Quercetin (QCT), natural flavonoid, multiple pharmacological activities. However, it not established whether QCT can protect against neuron inhibiting ferroptosis. In this study, we investigated potential antiferroptotic effects cellular models using specific ferroptosis inducers (Erastin RSL-3) MPP+. The were also explored MPTP-induced PD mouse models. counting kit-8 (CCK-8) assay was performed assess viability. Variations mitochondrial morphology evaluated transmission electron microscopy (TEM) while membrane potential, mass, ROS measured fluorescent probes. Lipid peroxidation levels assayed through measurement ROS, MDA, GSH, SOD levels. on behavioral disorders examined rotarod open field tests. vitro vivo, significantly inhibited activating nuclear factor erythroid 2-related 2 (Nrf2) protein. Additionally, ameliorated motor impairments protected loss Interestingly, Nrf2 knockdown alleviated protective conclusion, these results demonstrate that involved MPP+/MPTP-induced PD, inhibits Therefore, agent for preventing targeting

Language: Английский

Citations

103

Neuromelanin in Parkinson’s Disease: Tyrosine Hydroxylase and Tyrosinase DOI Open Access
Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe

et al.

International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(8), P. 4176 - 4176

Published: April 10, 2022

Parkinson’s disease (PD) is an aging-related and the second most common neurodegenerative after Alzheimer’s disease. The main symptoms of PD are movement disorders accompanied with deficiency neurotransmitter dopamine (DA) in striatum due to cell death nigrostriatal DA neurons. Two histopathological hallmarks exist PD: cytosolic inclusion bodies termed Lewy that mainly consist α-synuclein protein, oligomers which produced by misfolding regarded be neurotoxic, causing death; black pigments neuromelanin (NM) contained neurons markedly decrease PD. synthesis human NM similar melanin melanocytes; skin via DOPAquinone (DQ) tyrosinase, whereas DAquinone (DAQ) tyrosine hydroxylase (TH) aromatic L-amino acid decarboxylase (AADC). cytoplasm highly reactive assumed oxidized spontaneously or unidentified tyrosinase DAQ then, synthesized NM. Intracellular accumulation above a specific threshold has been reported associated neuron phenotypes. This review reports recent progress biosynthesis pathophysiology

Language: Английский

Citations

92

Nanozymes for Regenerative Medicine DOI
Xiaozhou Mou, Qingyuan Wu,

Zheao Zhang

et al.

Small Methods, Journal Year: 2022, Volume and Issue: 6(11)

Published: Oct. 6, 2022

Abstract Nanozymes refer to nanomaterials that catalyze enzyme substrates into products under relevant physiological conditions following kinetics. Compared natural enzymes, nanozymes possess the characteristics of higher stability, easier preparation, and lower cost. Importantly, magnetic, fluorescent, electrical properties nanomaterials, making them promising replacements for enzymes in industrial, biological, medical fields. On account rapid development recently, their application potentials regeneration medicine are gradually being explored. To highlight achievements field, this review summarizes catalytic mechanism four types representative nanozymes. Then, strategies improve biocompatibility discussed. covers recent advances tissue including wound healing, nerve defect repair, bone regeneration, cardiovascular disease treatment. In addition, challenges prospects nanozyme researches summarized.

Language: Английский

Citations

86

Pharmacological Inhibition of Ferroptosis as a Therapeutic Target for Neurodegenerative Diseases and Strokes DOI Creative Commons
Yumin Wang, Shuang Wu, Qiang Li

et al.

Advanced Science, Journal Year: 2023, Volume and Issue: 10(24)

Published: June 21, 2023

Emerging evidence suggests that ferroptosis, a unique regulated cell death modality is morphologically and mechanistically different from other forms of death, plays vital role in the pathophysiological process neurodegenerative diseases, strokes. Accumulating supports ferroptosis as critical factor diseases strokes, pharmacological inhibition therapeutic target for these diseases. In this review article, core mechanisms are overviewed roles strokes described. Finally, emerging findings treating through This demonstrates by bioactive small-molecule compounds (ferroptosis inhibitors) could be effective treatments highlights potential promising avenue used to prevent article will shed light on developing novel regimens slow down progression future.

Language: Английский

Citations

83

Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family in physiological and pathophysiological process and diseases DOI Creative Commons
Qian Lu, Yanli Zhu, Chao Deng

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2024, Volume and Issue: 9(1)

Published: March 1, 2024

Abstract Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) family (PGC-1s), consisting of three members encompassing PGC-1α, PGC-1β, and PGC-1-related coactivator (PRC), was discovered more than a quarter-century ago. PGC-1s are essential coordinators many vital cellular events, including mitochondrial functions, oxidative stress, endoplasmic reticulum homeostasis, inflammation. Accumulating evidence has shown that implicated in diseases, such as cancers, cardiac diseases cardiovascular neurological disorders, kidney motor system metabolic disorders. Examining the upstream modulators co-activated partners identifying critical biological events modulated by downstream effectors contribute to presentation elaborate network PGC-1s. Furthermore, discussing correlation between well summarizing therapy targeting helps make individualized precise intervention methods. In this review, we summarize basic knowledge regarding molecular regulatory network, discuss physio-pathological roles human review application PGC-1s, diagnostic prognostic value several therapies pre-clinical studies, suggest directions for future investigations. This presents immense potential treatment hopefully facilitates promotion new therapeutic targets.

Language: Английский

Citations

79

Targeting epigenetic and posttranslational modifications regulating ferroptosis for the treatment of diseases DOI Creative Commons
Yumin Wang, Jing Hu, Shuang Wu

et al.

Signal Transduction and Targeted Therapy, Journal Year: 2023, Volume and Issue: 8(1)

Published: Dec. 10, 2023

Abstract Ferroptosis, a unique modality of cell death with mechanistic and morphological differences from other modes, plays pivotal role in regulating tumorigenesis offers new opportunity for modulating anticancer drug resistance. Aberrant epigenetic modifications posttranslational (PTMs) promote resistance, cancer progression, metastasis. Accumulating studies indicate that can transcriptionally translationally determine vulnerability to ferroptosis functions as driver nervous system diseases (NSDs), cardiovascular (CVDs), liver diseases, lung kidney diseases. In this review, we first summarize the core molecular mechanisms ferroptosis. Then, roles processes, including histone PTMs, DNA methylation, noncoding RNA regulation such phosphorylation, ubiquitination, SUMOylation, acetylation, ADP-ribosylation, are concisely discussed. The PTMs genesis cancers, NSD, CVDs, well application PTM modulators therapy these then discussed detail. Elucidating mediated by will facilitate development promising combination therapeutic regimens containing or PTM-targeting agents inducers be used overcome chemotherapeutic resistance could prevent addition, highlight potential approaches chemoresistance halt

Language: Английский

Citations

77

Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy DOI
Amir Ajoolabady, Daolin Tang, Guido Kroemer

et al.

British Journal of Cancer, Journal Year: 2022, Volume and Issue: 128(2), P. 190 - 205

Published: Oct. 13, 2022

Language: Английский

Citations

73

Ferroptosis in Parkinson's disease: Molecular mechanisms and therapeutic potential DOI

Xv-shen Ding,

Li Gao, Han Zheng

et al.

Ageing Research Reviews, Journal Year: 2023, Volume and Issue: 91, P. 102077 - 102077

Published: Sept. 24, 2023

Language: Английский

Citations

68

Aerobic glycolysis is the predominant means of glucose metabolism in neuronal somata, which protects against oxidative damage DOI
Wei Yao,

QianQian Miao,

Qian Zhang

et al.

Nature Neuroscience, Journal Year: 2023, Volume and Issue: 26(12), P. 2081 - 2089

Published: Nov. 23, 2023

Language: Английский

Citations

62